Selected transactions
Region
Exclusive Advisor, Listing Sponsor and Sole Bookrunner for cancer diagnostic specialist Ipsogen.
Exclusive Financial Advisor to NASDAQ-listed Exelixis (EXEL) in completing the divestiture of their subsidiary CRO Artemis GmbH to Taconic (TAC).
Divestiture of Pharmaton SA, Lugano and Boehringer Ingelheim’s worldwide Natural Health Phyto-based Nutraceuticals, Vitamins and Mineral Supplements to Amway.
Completed divestiture of a broad-spectrum antibiotic (“Romifidine”) for feed use in Animal Health.
Completed the 100% acquisition of German respiratory medical devices company Steag MicroParts GmbH, Dortmund.
Completed acquisition of ID Lelystad’s Animal Health vaccine business.
Completed acquisition of Novartis’s OTC Laxative brand Dulcolax.
Exclusive financial advisor to MorphoSys in signing collaboration partnership with Boehringer Ingelheim.
Exclusive financial advisor to Teva in the acquisition of German Specialty Generics Company AWD Pharmaceuticals.
Lead Financial advisor to Bayer AG in their preparation of the acquisition of Aventis CropScience and completion of a detailed fairness opinion on alternative strategic options.
Exclusive financial advisor to Teva in the issuance of a convertible bond offering.
Exclusive Financial Advisor in the acquisition of DSM N.V.‘s Transparent Sheet Business, a cross-border transaction involving two production sites.